&lt;p&gt;Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis&lt;/p&gt;

3,830

2,336

Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). Methods: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2022 Statistical Update is the product of a full year’s worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year’s edition includes data on the monitoring and benefits of cardiovascular health in the population and an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease and healthy life expectancy. Results: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. Conclusions: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

Section: Prevalencementioning

confidence: 99%

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Tsao¹,

Aday²,

Almarzooq³

et al. 2022

3,830

2,336

“…The prevalence of MetS has been noted to be high in individuals with certain conditions, including schizophrenia spectrum disorders 14 and bipolar disorder 15 ; prior solid organ transplantations 16 ; prior hematopoietic cell transplantation 17,18 ; HIV infection 19 ; COPD 20 ; prior treatment for blood cancers 18,21 ; systemic inflammatory disorders such as psoriasis, 22,23 systemic lupus erythematosus, 24 ankylosing spondylitis, 25 and rheumatoid arthritis 26,27 ; multiple sclerosis 28 ; type 1 diabetes 29,30 ; latent autoimmune diabetes in adults 30 ; prior gestational diabetes 31 ; prior pregnancy-induced hypertension 32 ; acne keloidalis nuchae 33 ; periodontitis 34,35 ; gallstones 36 ; cerebral palsy 37 ; war-related bilateral lower-limb amputation 38 or spinal cord injury 39 in veterans; and chronic opiate dependence, 40 as well as in individuals in select professions, including law enforcement, 41 commercial truck driving, 42 and firefighting. 43…”

Section: Metabolic Syndromementioning

confidence: 99%

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

Tsao¹,

Aday²,

Almarzooq³

et al. 2023

3,590

702

BACKGROUND: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). METHODS: The American Heart Association, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2023 Statistical Update is the product of a full year’s worth of effort in 2022 by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. The American Heart Association strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional COVID-19 (coronavirus disease 2019) publications, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains. RESULTS: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

“…The prevalence of MetS has been noted to be higher in individuals with certain conditions, including schizophrenia spectrum disorders 14 and bipolar disorder 15 ; prior solid organ transplantations 16 ; prior hematopoietic cell transplantation 17,18 ; HIV infection 19 ; chronic obstructive pulmonary disease 20 ; prior treatment for blood cancers 18,21 ; systemic inflammatory disorders such as psoriasis, 22,23 systemic lupus erythematosus, 24 ankylosing spondylitis, 25 and rheumatoid arthritis 26,27 ; multiple sclerosis 28 ; type 1 diabetes 29,30 ; latent autoimmune diabetes in adults 30 ; prior gestational diabetes 31 ; prior pregnancy-induced hypertension 32 ; acne keloidalis nuchae 33 ; periodontitis 34,35 ; gallstones 36 ; cerebral palsy 37 ; war-related bilateral lower-limb amputation 38 or spinal cord injury 39 in veterans; and chronic opiate dependence, 40 as well as in individuals in select professions, including law enforcement, 41 commercial truck driving, 42 and firefighting. 43…”

Section: Metabolic Syndromementioning

confidence: 99%

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Martin,

Aday,

Almarzooq

et al. 2024

476

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and metabolic syndrome) that contribute to cardiovascular health. The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). METHODS: The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members. The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional global data, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains. RESULTS: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.